House lawmakers return to Washington today as they seek to clear a full slate of legislative priorities. The lower chamber’s week will start with consideration of 38 bills under suspension of the rules. Among the bills under consideration include two Senate-passed bills — The Patient Right to Know Drug Prices Act (S. 2554) and the Know The Lowest Price Act (S. 2553) — that seek to crack down on the use of “gag clauses” that prevent pharmacists from telling customers that they could save money by paying cash out-of-pocket rather than using their insurance benefit. S. 2554 applies to all private insurance plans, whereas S. 2553 covers Medicare Part D and Medicare Advantage plans.
Meanwhile, the Senate will reconvene this morning and continue work on the presidential nominations queue. Senators will resume consideration of Peter Feldman to be Commissioner of the Consumer Product Safety Commission (CPSC), with a final confirmation vote expected later this afternoon.